![Johnson & Johnson Logo](https://ik.imagekit.io/kkbzr2uz4cp/stock/nyse/jnj.png?tr=w-200)
Johnson & Johnson
NYSE:JNJ
![Johnson & Johnson Logo](https://ik.imagekit.io/kkbzr2uz4cp/stock/nyse/jnj.png)
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Realty Income Corp
NYSE:O
|
Real Estate
|
US |
![]() |
Walt Disney Co
NYSE:DIS
|
Media
|
US |
![]() |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
144.38
174.48
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
Abbvie Inc
NYSE:ABBV
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
3M Co
NYSE:MMM
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Realty Income Corp
NYSE:O
|
US |
![]() |
Walt Disney Co
NYSE:DIS
|
US |
![]() |
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
![](https://ik.imagekit.io/kkbzr2uz4cp/stock/nyse/jnj.png)
Intrinsic Value
Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. [ Read More ]
The intrinsic value of one
JNJ
stock under the Base Case scenario is
159.93
USD.
Compared to the current market price of 161.02 USD,
Johnson & Johnson
is
Overvalued by 1%.
![](https://ik.imagekit.io/kkbzr2uz4cp/stock/nyse/jnj.png?tr=w-200)
Valuation Backtest
Johnson & Johnson
Run backtest to discover the historical profit from buying and selling
JNJ
stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Johnson & Johnson
Current Assets | 57B |
Cash & Short-Term Investments | 26.2B |
Receivables | 14.9B |
Other Current Assets | 15.8B |
Non-Current Assets | 115B |
Long-Term Investments | 4.5B |
PP&E | 19.6B |
Intangibles | 70.9B |
Other Non-Current Assets | 19.9B |
Current Liabilities | 48.7B |
Accounts Payable | 8.2B |
Accrued Liabilities | 28.7B |
Short-Term Debt | 6.3B |
Other Current Liabilities | 5.6B |
Non-Current Liabilities | 53.2B |
Long-Term Debt | 25.1B |
Other Non-Current Liabilities | 28.1B |
Earnings Waterfall
Johnson & Johnson
Revenue
|
86.6B
USD
|
Cost of Revenue
|
-26.4B
USD
|
Gross Profit
|
60.2B
USD
|
Operating Expenses
|
-35.2B
USD
|
Operating Income
|
25B
USD
|
Other Expenses
|
13B
USD
|
Net Income
|
38B
USD
|
Free Cash Flow Analysis
Johnson & Johnson
USD | |
Free Cash Flow | USD |
JNJ Profitability Score
Profitability Due Diligence
Johnson & Johnson's profitability score is 71/100. The higher the profitability score, the more profitable the company is.
![](https://ik.imagekit.io/kkbzr2uz4cp/stock/nyse/jnj.png)
Score
Johnson & Johnson's profitability score is 71/100. The higher the profitability score, the more profitable the company is.
JNJ Solvency Score
Solvency Due Diligence
Johnson & Johnson's solvency score is 63/100. The higher the solvency score, the more solvent the company is.
![](https://ik.imagekit.io/kkbzr2uz4cp/stock/nyse/jnj.png)
Score
Johnson & Johnson's solvency score is 63/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
JNJ Price Targets Summary
Johnson & Johnson
According to Wall Street analysts, the average 1-year price target for
JNJ
is 174.9 USD
with a low forecast of 151.5 USD and a high forecast of 225.75 USD.
Ownership
JNJ Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Price Appreciation
JNJ Price
Johnson & Johnson
Average Annual Return | 10.11% |
Standard Deviation of Annual Returns | 2.5% |
Max Drawdown | -27% |
Market Capitalization | 387.5B USD |
Shares Outstanding | 2 406 680 000 |
Percentage of Shares Shorted | 0.88% |
JNJ News
Last Important Events
Johnson & Johnson
Significant happenings or occurrences that are of interest to investors. These could be company-specific developments or market-wide shifts.
Sentiment Analysis
Johnson & Johnson
Company Profile
![Johnson & Johnson Logo](https://ik.imagekit.io/kkbzr2uz4cp/stock/nyse/jnj.png?tr=w-200)
![Johnson & Johnson Logo](https://ik.imagekit.io/kkbzr2uz4cp/stock/nyse/jnj.png?tr=w-200)
Country
Industry
Market Cap
Dividend Yield
Description
Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. The company is headquartered in New Brunswick, New Jersey and currently employs 141,700 full-time employees. The firm operates through three segments: Consumer Health, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being. The Consumer Health segment includes a range of products that is focused on personal healthcare used in the skin health/beauty, over-the-counter medicines, baby care, oral care, women’s health and wound care markets. The Pharmaceutical segment is focused on six therapeutic areas: Immunology, Infectious Diseases, Neuroscience, Oncology, Cardiovascular and Metabolism and Pulmonary Hypertension. The Medical Devices segment includes a range of products used in the interventional solutions, orthopaedics, surgery, and vision fields. Its geographic area includes the United States, Europe, Western Hemisphere (excluding the United States), and Africa, Asia and Pacific.
Contact
IPO
Employees
Officers
The intrinsic value of one
JNJ
stock under the Base Case scenario is
159.93
USD.
Compared to the current market price of 161.02 USD,
Johnson & Johnson
is
Overvalued by 1%.